ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ALNEV Neovacs

0.0003
0.0001 (50.00%)
Last Updated: 13:54:55
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Year End 31 December 2023 20162017201820192020202120222023
EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)
Total Revenue 342k813k114k171k30k34k473k534k
Operating Income -17.16M-18.71M-13.08M-8.18M-3.49M-7.83M-5.98M-6.91M
Pre Tax Income -17.33M-18.86M-13.55M-9.3M-6.68M-12.48M-4.35M-9.62M
Net Income -13.93M-14.84M-10.78M-7.55M-6.14M-11.84M-3.55M-8.74M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -0.313-0.213-0.099-0.047-0.009-0.001-0.015-0.002
EBIT -17.13M-18.6M-13.08M-9.17M-4.56M-10.6M-7.01M-7.47M
EBITDA -17.13M-18.25M-13.02M-8.12M-3.44M-7.73M-5.83M-6.74M